MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2021-22)
- Udyam number
- UDYAM-HR-03-0000131
Psychotropics India Limited - pharma in Faridabad, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹261.89 Cr
▼ 8% YoY
Net profit · FY 2025
₹10.18 Cr
Net margin 3.9%
EBITDA · FY 2025
₹26.4 Cr
EBITDA margin 10.1%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹10.5 Cr
Issued & subscribed
Open charges
₹86.22 Cr
Satisfied ₹63.6 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
878
Provident fund records
About Psychotropics India Limited
Data last updated:
Psychotropics India Limited is a public limited company based in Faridabad, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 July 1986 and has been in existence for over 40 years.
Its director Anand Kumar Jain and family are #1,673 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85194HR1986PLC071264. Its GSTIN is 06AAACP3834G1ZN (Haryana). The company holds 17 GST registrations, of which 12 are active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹10.5 Cr. It was formerly known as Psychotropics India Private Limited and Visaj Garments Private Limited. It is led by directors including Siddharth Chawla (Managing Director) and Navdeep Chawla (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 17 Sector 20A Faridabad – 121001, Haryana, India – 121001.
As per the financials filed for FY 2025, the company reported a revenue of ₹261.89 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹10.18 Cr (net margin 3.9%) and EBITDA of ₹26.4 Cr (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 2% over five years.
The company has about 878 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Psychotropics India. As per MCA filings, the company has open charges of ₹86.22 Cr and satisfied charges of ₹63.6 Cr on record. Court records list 75 cases involving the company, including 36 filed by the company and 39 filed against it; 27 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.02 Cr; the latest was in October 2009. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Selmar Lab Private Limited with revenue of ₹269.27 Cr. The company has 15 MSME Form 1 returns on record between 2019 and 2023, listing 530 overdue payments to 41 micro and small suppliers.
Psychotropics India Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-03-0000131). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pilindia.in.
Company details
CIN U85194HR1986PLC071264
Registration Number 071264
Incorporation Date 08 July 1986
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-03-0000131
Name history
Psychotropics India has undergone 2 name changes throughout its history. The company was previously known as Psychotropics India Private Limited, and Visaj Garments Private Limited. The current legal name is Psychotropics India Limited.
| Company Name | Status |
|---|---|
| Psychotropics India Limited | Current |
| Psychotropics India Private Limited | Previous |
| Visaj Garments Private Limited | Previous |
CIN history
Psychotropics India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U85194HR1986PLC071264, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85194HR1986PLC071264 | Current |
| U85194DL1996PLC083911 | Previous |
| U85194HR1996PLC071264 | Previous |
Key People
Siddharth Chawla Managing Director Navdeep Chawla Whole-Time Director Amita Chawla Whole-Time Director Recognitions & Rankings of Psychotropics India
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,673 Anand Kumar Jain & family ₹1,100 Cr
Contact details
Psychotropics India Limited's registered office is in Faridabad, Haryana. Its website is pilindia.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 17 Sector 20A Faridabad – 121001, Haryana, India – 121001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Psychotropics India Limited, buy the company report.
Comprehensive company report
Psychotropics India Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Psychotropics India operates one associated brand: Psychotropics India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Development of quality medicines at affordable prices in the healthcare sector. | pilindia.in |
Business activity
The main business activity of Psychotropics India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Psychotropics India Limited, buy the company report.
Financials of Psychotropics India Limited
FY 2025 filings availablePsychotropics India Limited reported revenue of ₹261.89 Cr (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹261.89 Cr ▼ 8%
Net profit · FY 2025
₹10.18 Cr margin 3.9%
EBITDA · FY 2025
₹26.4 Cr margin 10.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 4%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▼ 8%
5 years · compounded
▼ 6%
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.18 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Psychotropics India Limited, buy the company report.
Board of directors of Psychotropics India Limited
Psychotropics India has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navdeep Chawla | Whole-Time Director | 18 Dec 1996 | 29 Years 10 Months | Current |
| Siddharth Chawla Also directs: Indo Autotech Ltd., Pil Pharmaceuticals Limited | Managing Director | 31 Mar 2006 | 20 Years 7 Months | Current |
| Amita Chawla | Whole-Time Director | 31 Dec 2008 | 17 Years 10 Months | Current |
| Satish Dev Jain Also directs: BM Continental Granites & Minerals Limited, Indo Autotech Ltd., Sarvo Technologies Limited and 4 more | Director | 27 Dec 2024 | 1 Years 10 Months | Current |
| Anand Kumar Jain | Director | 02 Apr 2024 | 2 Years 7 Months | Current |
Peer comparison
Psychotropics India Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Selmar Lab Private Limited | ₹269.27 Cr (FY 2024) | -14.0% | Hyderabad, Telangana, India | |||
| Til Healthcare Private Limited | ₹266.59 Cr (FY 2025) | 13.0% | Chennai, Tamil Nadu, India | |||
| Panacea Biotec Pharma Limited | ₹265.23 Cr (FY 2025) | 26.0% | New Delhi, Delhi, India | |||
| Dey's Medical Stores Pvt Ltd | ₹262.47 Cr (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Psychotropics India Limitedthis company | ₹261.89 Cr (FY 2025) | ₹10.18 Cr | 3.9% | -8.0% | 878 | Faridabad, Haryana, India |
| Nanz Med Science Pharma Private Limited | ₹258.64 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India | |||
| Abaris Healthcare Private Limited | ₹257.73 Cr (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Pretty Petals Private Limited | ₹251.52 Cr (FY 2025) | 21.0% | New Delhi, Delhi, India |
To see the full peer comparison of Psychotropics India Limited, buy the company report.
Auditor
Psychotropics India Limited is audited by S.R. BATLIBOI & Co. LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R. BATLIBOI & Co. LLP | FY 2024 | 301003E/E00005 |
Shareholding
The shareholding of Psychotropics India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Psychotropics India Limited, buy the company report.
Charges & borrowings
Open charges
₹86.22 Cr
Satisfied charges
₹63.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Apr 2025 | 101097788 | Others | ₹2 Cr | Open | |
| 25 Jul 2024 | 100963917 | Others | ₹15 Cr | Open | |
| 26 Apr 2024 | 100924494 | Others | ₹8 Cr | Open | |
| 27 Nov 2023 | 100858396 | Axis Bank Limited | ₹99.3 Lakh | Open | |
| 13 Dec 2022 | 100661240 | Axis Bank Limited | ₹70 Lakh | Open |
To see the full charge records of Psychotropics India Limited, buy the company report.
Total charge records: 20 View all charges
Deals & funding
Psychotropics India Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.02 Cr; the latest was in October 2009.
Total deals
6
Funding rounds
4
Secondary share transfers
2
Disclosed funding
₹3.02 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2009 | Funding round | ₹95 Lakh | Investors: Psychotropics Leasing & Finance Private Limited |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Psychotropics Leasing & Finance Private Limited |
| Jan 2009 | Funding round | ₹87.1 Lakh | Investors: Psychotropics Leasing & Finance Private Limited, Navdeep Chawla & Sons HUF, 2 individuals |
| Jan 2008 | Secondary share transfer | Undisclosed | Buyer: Psychotropics Leasing & Finance Private Limited Seller: 3 individuals |
| May 2007 | Funding round | ₹1 Cr | Investors: Psychotropics Leasing & Finance Private Limited |
To see the full deal history of Psychotropics India Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Psychotropics India Limited has 75 court cases on record: 36 filed by Psychotropics India, 39 filed against it. 27 cases are pending and 48 are disposed.
Total cases
75
Filed by the company
36
Filed against the company
39
Pending
27
Disposed
48
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 46 | 21 | 21 |
| High courts | 28 | 17 | 5 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 75)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CM(M)) | Filed against the company by M/S Novita Healthcare Pvt Ltd | Pending |
| High Court of Delhi | Court case (CM(M)-IPD) | Filed against the company by M/S Novita Healthcare Pvt Ltd | Pending |
| District court, Dehradun, Uttarakhand | Commercial suit | Filed by the company against Nifty Labs Pvt. Ltd | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against Quality Bestochem Formulations P Ltd and Anr | Pending |
| District court, Faridabad, Haryana | Cheque dishonour complaint | Filed by the company against M/S Medi Xpert India Ltd. and 1 other | Pending |
To see the full case history of Psychotropics India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Psychotropics India Limited was last rated by Crisil on 03 Jul 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 03 Jul 2019 |
To see the full credit ratings and regulatory alerts of Psychotropics India Limited, buy the company report.
MSME payment delays
Psychotropics India Limited has 15 MSME Form 1 returns on record between 2019 and 2023, listing 530 overdue payments to 41 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 41)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Alutech Packaging Private Limited | |||
| Aarvis International | |||
| Corel Pharma Chem | |||
| Krishna Enterprises | |||
| Vasundhara Industries |
To see the full MSME payment records of Psychotropics India Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Psychotropics India has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
1
Associated companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Pil Pharmaceuticals Limited | U24233HR2007PLC072072 |
To see the full group structure of Psychotropics India Limited, buy the company report.
Employees & EPFO
Psychotropics India Limited has a workforce of 878 employees on its EPFO records as of Apr 07, 2024, across 5 active EPFO establishments.
Employee count
878
Active EPFO establishments
5
Employee growth
-11.94%
GST
Psychotropics India has 17 GST registrations: 12 active and 5 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
17
Active
12
Cancelled / inactive
5
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACP3834G1ZN | Haryana | Active | 01 Jul 2017 |
| 05AAACP3834G1ZP | Uttarakhand | Active | 01 Jul 2017 |
| 29AAACP3834G3ZD | Karnataka | Active | 04 Oct 2023 |
| 27AAACP3834G1ZJ | Maharashtra | Active | 03 Nov 2023 |
To see the full GST registrations and return filing status of Psychotropics India Limited, buy the company report.
Recent activity
Psychotropics India Limited has 16 board changes on record since 1996: 5 appointments and 11 cessations. The latest: Anand Kumar Jain ceased to be Additional Director on 29 Dec 2024.
AGM
Psychotropics India Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101097788 was registered on 29 Apr 2025.
Charges
A charge with Others of Rs. 15.00 Cr registered on 25 Jul 2024 with Charge ID 100963917 was modified on 11 Apr 2025.
Charges
A charge with Others of Rs. 8.00 Cr registered on 26 Apr 2024 with Charge ID 100924494 was modified on 11 Apr 2025.
Filing
Psychotropics India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Anand Kumar Jain ceased to be Additional Director.
Ceased
Satish Dev Jain ceased to be Additional Director.
Appointed
Satish Dev Jain was appointed as Director.
Ceased
Sajan Kumar Jain ceased to be Director.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100963917 was registered on 25 Jul 2024.
Charges
A charge registered on 28 Jun 2023 via Charge ID 100754404 with Others was fully satisfied on 10 May 2024.
Charges
A charge registered on 30 Nov 2016 via Charge ID 100063023 with Others was fully satisfied on 08 May 2024.
48 earlier events are in the company report.
Frequently asked questions
Psychotropics India is an active public limited company based in Faridabad, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 July 1986 (40+ years old) and is registered under CIN U85194HR1986PLC071264.
Psychotropics India has 5 current directors:
- Siddharth Chawla - Managing Director
- Navdeep Chawla - Whole-Time Director
- Amita Chawla - Whole-Time Director
- Satish Dev Jain - Director
- Anand Kumar Jain - Director
The latest financial statements of Psychotropics India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Psychotropics India is 06AAACP3834G1ZN, registered in Haryana. The company has 17 GST registrations in all, of which 12 are active and 5 are cancelled or inactive. Other active GSTINs include 05AAACP3834G1ZP (Uttarakhand), 29AAACP3834G3ZD (Karnataka), 27AAACP3834G1ZJ (Maharashtra).
The CIN (Corporate Identification Number) of Psychotropics India is U85194HR1986PLC071264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Psychotropics India has 75 court cases on record: 36 filed by the company and 39 filed against it. 27 are pending. Most are in the district courts.
Psychotropics India was incorporated on 08 July 1986, making it 40+ years old. It is registered with the Registrar of Companies, Delhi.
Psychotropics India has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.02 Cr; the latest was in October 2009.
The peers of Psychotropics India by revenue are Selmar Lab Private Limited, Til Healthcare Private Limited, Panacea Biotec Pharma Limited, Dey's Medical Stores Pvt Ltd, Nanz Med Science Pharma Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anand Kumar Jain ceased to be Additional Director on 29 Dec 2024. Satish Dev Jain ceased to be Additional Director on 29 Dec 2024. Satish Dev Jain was appointed as Director on 27 Dec 2024. Psychotropics India has 16 board changes on record in total.
Yes, Psychotropics India is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-03-0000131).
Psychotropics India has 15 MSME Form 1 returns on record between 2019 and 2023, listing 530 overdue payments to 41 micro and small suppliers. The latest return was filed on 15 Dec 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages